See more : Yoma Strategic Holdings Ltd. (Z59.SI) Income Statement Analysis – Financial Results
Complete financial analysis of Vicarious Surgical Inc. (RBOT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vicarious Surgical Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- United States Steel Corporation (X) Income Statement Analysis – Financial Results
- UnitedHealth Group Incorporated (UNH.BA) Income Statement Analysis – Financial Results
- Univa Foods Limited (UNIVAFOODS.NS) Income Statement Analysis – Financial Results
- PennantPark Investment Corporation (PNNT) Income Statement Analysis – Financial Results
- National Aluminium Company Limited (NATIONALUM.BO) Income Statement Analysis – Financial Results
Vicarious Surgical Inc. (RBOT)
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.85M | 1.94M | 316.00K | 0.00 | 0.00 |
| Gross Profit | -1.85M | -1.94M | -316.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 47.58M | 43.90M | 22.10M | 9.80M | 7.48M |
| General & Administrative | 26.86M | 29.72M | 13.50M | 2.33M | 2.05M |
| Selling & Marketing | 6.23M | 6.46M | 2.98M | 861.00K | 250.00K |
| SG&A | 33.09M | 36.18M | 16.47M | 3.19M | 2.30M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Cost & Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
| Interest Income | 4.43M | 1.44M | 20.00K | 113.00K | 469.00 |
| Interest Expense | 25.00K | 200.00K | 89.00K | 3.00K | 0.00 |
| Depreciation & Amortization | 1.85M | 1.94M | 316.00K | 157.00K | 104.00K |
| EBITDA | -69.19M | 7.30M | -34.80M | -161.18K | -9.68M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -80.67M | -80.08M | -38.57M | -12.99M | -9.78M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 9.60M | 85.24M | 3.02M | 110.00K | 469.00K |
| Income Before Tax | -71.07M | 5.16M | -7.27M | -12.88M | -9.31M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -84.00M | -227.00K | 3.00K | -67.86K |
| Net Income | -71.07M | 89.16M | -7.04M | -12.88M | -9.31M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -14.70 | 20.77 | -2.19 | -4.91 | -1.70 |
| EPS Diluted | -14.60 | 20.99 | -2.19 | -4.91 | -1.70 |
| Weighted Avg Shares Out | 4.83M | 4.29M | 3.22M | 2.62M | 5.47M |
| Weighted Avg Shares Out (Dil) | 4.87M | 4.25M | 3.22M | 2.62M | 5.47M |
Vicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Adam Sachs - CEO William Kelly - CFO Conference Call Participants Ryan Zimmerman - BTIG Operator Good afternoon,...
Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for...
Vicarious Surgical to Participate in TD Cowen's 44th Annual Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will...
Vicarious Surgical to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter...
Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that Randy Clark...
Vicarious Surgical to Present at the Piper Sandler 35th Annual Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will...
Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Kaitlyn Brosco - Investor Relations Adam Sachs - Chief Executive Officer Bill Kelly - Chief Financial Officer Conference Call Participants Ryan Zimmerman...
Vicarious Surgical Reports Third Quarter 2023 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for...
Vicarious Surgical to Report Third Quarter 2023 Financial Results on November 13, 2023
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the third quarter...
Vicarious Surgical Receives Continued Listing Standard Notice From NYSE
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that on September...
Source: https://incomestatements.info
Category: Stock Reports